1. Home
  2. BNZI vs KTTA Comparison

BNZI vs KTTA Comparison

Compare BNZI & KTTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Banzai International Inc.

BNZI

Banzai International Inc.

HOLD

Current Price

$1.15

Market Cap

15.7M

Sector

N/A

ML Signal

HOLD

Logo Pasithea Therapeutics Corp.

KTTA

Pasithea Therapeutics Corp.

HOLD

Current Price

$0.84

Market Cap

16.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BNZI
KTTA
Founded
2016
2020
Country
United States
United States
Employees
28
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
15.7M
16.2M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
BNZI
KTTA
Price
$1.15
$0.84
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$23.00
$3.00
AVG Volume (30 Days)
845.9K
171.0K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$185.61
N/A
Revenue Next Year
$32.86
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.54
$0.28
52 Week High
$4.44
$2.34

Technical Indicators

Market Signals
Indicator
BNZI
KTTA
Relative Strength Index (RSI) 45.85 50.75
Support Level $1.07 $0.68
Resistance Level $1.40 $0.88
Average True Range (ATR) 0.12 0.07
MACD -0.00 0.02
Stochastic Oscillator 30.88 71.88

Price Performance

Historical Comparison
BNZI
KTTA

About BNZI Banzai International Inc.

Banzai International Inc is a marketing technology (MarTech) company that produces data-driven marketing and sales solutions for businesses of all sizes. Its mission is to help its customers accomplish their mission by enabling marketing, sales and customer engagement outcomes. The company has two reportable operating segments, Banzai Operating and OpenReel. The company's segments deliver SaaS tools that leverage data, analytics, and AI to provide marketing and sales solutions for business of all size. it derives maximum revenue from Banzai Operating segment. Geographically, it operates in Americas, Europe, Middle East and Africa (EMEA), and Asia Pacific.

About KTTA Pasithea Therapeutics Corp.

Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. Its pipeline includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module).

Share on Social Networks: